Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:43 PM
Ignite Modification Date:
2025-12-26 @ 2:43 PM
NCT ID:
NCT01295606
Eligibility Criteria:
Inclusion Criteria:
* signed parental informed written consent
* neonates to whom cefazolin is administered by intravenous route for clinical indications (invasive procedure)
Exclusion Criteria:
* known cefazolin intolerance
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
28 Days
Study:
NCT01295606
Study Brief:
Protocol Section:
NCT01295606